SonoThera is entering a clinical execution phase, advancing multiple genetic medicine programs toward first-in-human studies. Lead clinical programs include Duchenne muscular dystrophy (DMD), ...

There is a danger that population genetic screening programs may be introduced without the necessary scrutiny and rigor that is usually applied when screening programs are put into effect, experts ...

For years, the promise of genetic testing has been clear: Identify people at elevated risk for cancer and intervene before the disease develops or when it's most treatable. Yet millions of Americans ...

Even as it's become clear that an inherited susceptibility to some cancers is more common than once thought, genetic testing of family members of cancer patients hasn't increased as much as experts ...